Insider Transactions in Q3 2021 at Kiora Pharmaceuticals Inc (KPRX)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 02
2021
|
Brenda Mann VP of Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
61
-0.4%
|
$61
$1.81 P/Share
|
|
Sep 02
2021
|
Sarah Romano Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
84
-0.36%
|
$84
$1.81 P/Share
|
|
Sep 02
2021
|
Stephen From Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
253
-0.37%
|
$253
$1.81 P/Share
|
|
Aug 03
2021
|
Sarah Romano Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
87
-0.37%
|
$174
$2.4 P/Share
|
|
Aug 03
2021
|
Brenda Mann VP of Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
63
-0.41%
|
$126
$2.4 P/Share
|
|
Aug 03
2021
|
Michael P. Manzo VP of Engineering |
SELL
Payment of exercise price or tax liability
|
Direct |
65
-0.42%
|
$130
$2.4 P/Share
|
|
Aug 03
2021
|
Stephen From Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
261
-0.38%
|
$522
$2.4 P/Share
|
|
Aug 02
2021
|
Armistice Capital, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
192,775
-19.72%
|
$385,550
$2.4 P/Share
|
|
Jul 30
2021
|
Armistice Capital, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
68,188
-6.52%
|
$136,376
$2.69 P/Share
|
|
Jul 29
2021
|
Armistice Capital, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
400,000
-27.66%
|
$1,200,000
$3.0 P/Share
|
|
Jul 28
2021
|
Armistice Capital, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
375,443
-20.61%
|
$1,126,329
$3.28 P/Share
|
|
Jul 27
2021
|
Armistice Capital, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
2,377,695
-15.03%
|
$11,888,475
$5.47 P/Share
|
|
Jul 27
2021
|
Armistice Capital, LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
852,500
+16.88%
|
$3,410,000
$4.8 P/Share
|
|
Jul 02
2021
|
Stephen From Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
877
-1.25%
|
$2,631
$3.7 P/Share
|
|
Jul 02
2021
|
Brenda Mann VP of Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
154
-0.99%
|
$462
$3.7 P/Share
|
|
Jul 02
2021
|
Michael P. Manzo VP of Engineering |
SELL
Payment of exercise price or tax liability
|
Direct |
160
-1.03%
|
$480
$3.7 P/Share
|
|
Jul 02
2021
|
Sarah Romano Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
180
-0.76%
|
$540
$3.7 P/Share
|